# Extracorporeal Shock Wave Therapy in Enhancing Sensitivity and Postural Stability in Multiple Sclerosis

> **NCT07514104** · NA · COMPLETED · sponsor: **Furkan Bilek** · enrollment: 54 (actual)

## Conditions studied

- Multiple Sclerosis
- Multiple Sclerosis (MS) - Relapsing-remitting
- Sensorimotor Gait Disorder

## Interventions

- **OTHER:** Extracorporeal Shock Wave Therapy (ESWT)

## Key facts

- **NCT ID:** NCT07514104
- **Lead sponsor:** Furkan Bilek
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-01
- **Primary completion:** 2025-02-15
- **Final completion:** 2025-10-15
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07514104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07514104, "Extracorporeal Shock Wave Therapy in Enhancing Sensitivity and Postural Stability in Multiple Sclerosis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT07514104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*